ClinicalTrials.Veeva

Menu

The Diversity of the Fungal and Bacterial in Colon Mucosa of Patients With Different Degree of Inflammation of Ulcerative Colitis

X

Xiuli Zuo

Status

Unknown

Conditions

Ulcerative Colitis

Treatments

Other: ulcerative colitis
Other: Control

Study type

Observational

Funder types

Other

Identifiers

NCT03151850
2015SDU-QILU-G004

Details and patient eligibility

About

We analyzed the diversity of the fungal and bacterial within colon mucosa between patients with different degree of inflammation of Ulcerative Colitis.

Full description

In recent years, the relationship of intestinal fungus with inflammatory bowel disease was gradually revealed. We divided the patients with ulcerative colitis into three groups on the basis of World Gastroenterology Organisation (WGO) classification about inflammation degree and progress classification and established the healthy control group. Analyzing the diversity of the fungal and bacterial within colon mucosa between patients with different clinical classification, for example, the proportion of bacteria and fungi, the proportion of candida albicans, the proportion of yeasts, and so on.

Enrollment

50 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Patients at our tertiary care medical center, aged between 18 and 80 years, scheduled to undergo surveillance colonoscopy.
  • The patients with ulcerative colitis for ulcerative colitis group.
  • The patients without ulcerative colitis for control group.
  • 18-80 years.

Exclusion criteria

  • Using antibiotics, glucocorticoid and immunosuppressants wintin one month.
  • There are contraindications for enteroscopy and biopsy.
  • There are other intestinal diseases.
  • Pregnancy or breast-feeding women.
  • Patients with serious lung disease and mental illness.

Trial design

50 participants in 2 patient groups

ulcerative colitis
Description:
We analysed the diversity of the fungal and bacterial in patients with Ulcerative Colitis (UC). We take 2 pieces of biopsies in the sigmoid colon mucosa inflammation area during the colonoscopy and then perform gene sequencing.
Treatment:
Other: ulcerative colitis
Control
Description:
Analysing the diversity of the fungal and bacterial in patients without ulcerative colitis. We take 2 pieces of biopsies in the sigmoid colon mucosa during the colonoscopy and then perform gene sequencing.
Treatment:
Other: Control

Trial contacts and locations

1

Loading...

Central trial contact

Xiuli Zuo, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems